Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence

Cited by (523)

Items 301–400 of 523

  1. Clinical Insights Into the Biology and Treatment of Pancreatic Cancer
    Niharika B. Mettu, James L. Abbruzzese · 2016 · Journal of Oncology Practice
  2. KLF2 induces the senescence of pancreatic cancer cells by cooperating with FOXO4 to upregulate p21
    Dai Yuedi, Liu Houbao, Pinxiang Lu, Wang Hui, Tao Min, Zhang Dexiang · 2019 · Experimental Cell Research
  3. Liquid biopsy approach to pancreatic cancer
    Sonia Perales, Carolina Torres, Cristina Jiménez‐Luna, Jose Carlos Prados, Joaquina Martínez-Galán, Jose Manuel Sanchez-Manas, Octavio Caba · 2021 · World Journal of Gastrointestinal Oncology
  4. The Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma
    Angelo Porciuncula, Cristina H Hajdu, Gregory David · 2016 · Advances in cancer research
  5. Inflammatory cytokines and angiogenic factors as potential biomarkers in South African pancreatic ductal adenocarcinoma patients: A preliminary report
    Yandiswa Yolanda Yako, Martin Brand, Martin Smith, Deirdré Kruger · 2017 · Pancreatology
  6. Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis
    Paul C. McDonald, James Thomas Topham, Shannon J. Awrey, Hossein Tavakoli, Rebekah Carroll, Wells S. Brown, Zachary J. Gerbec, Steve E. Kalloger, Joanna M. Karasinska, Patricia A. Tang et al. · 2025 · Communications Biology
  7. Immunosenescence in digestive system cancers: Mechanisms, research advances, and therapeutic strategies
    Junyan Zhang, Xiaojiao Guan, Xinwen Zhong · 2024 · Seminars in Cancer Biology
  8. Organotypic Culture of Acinar Cells for the Study of Pancreatic Cancer Initiation
    Alessandro Carrer, Carlotta Paoli · 2020 · Cancers
  9. K‐RasV14I‐induced Noonan syndrome predisposes to tumour development in mice
    Hernández‐Porras, Isabel, Schuhmacher, Alberto J, Garcia‐Medina, Raquel, Jiménez, Beatriz, Cañamero, Marta, de Martino, Alba, Guerra, Carmen · 2016 · The Journal of Pathology
  10. Senescence, Aging and Disease Throughout the Gastrointestinal System
    Sofía Ferreira-González, Tomonori Matsumoto, Eiji Hara, Stuart John Forbes · 2025 · Gastroenterology
  11. IL-8–Positive Tumor-Infiltrating Inflammatory Cells Are a Novel Prognostic Marker in Pancreatic Ductal Adenocarcinoma Patients
    Yuan Fang, Hexige Saiyin, Xinping Zhao, Yanhua Wu, Xu Han, Wenhui Lou · 2015 · Pancreas
  12. The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate
    Zhou Chen, Zhengfeng Wang, Yan Du, Huaqing Shi, Wence Zhou · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  13. Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice
    Yaser Salaymeh, Marganit Farago, Shulamit Sebban, Batel Shalom, Eli Pikarsky, Shulamit Katzav · 2020 · Life Science Alliance
  14. Senescence program and its reprogramming in pancreatic premalignancy
    Kailing Yang, Xiaojia Li, Keping Xie · 2023 · Cell Death and Disease
  15. The Tree Shrew as a Model for Cancer Research
    Tao Lu, Hongmei Peng, Liping Zhong, Pan Wu, Jian Guo He, Zhiming Deng, Yong Huang · 2021 · Frontiers in Oncology
  16. Chemoprevention of Gastrointestinal Cancer: The Reality and the Dream
    Kyung‐Soo Chun, Eun‐Hee Kim, Soo-Yeon Lee, Ki Baik Hahm · 2013 · Gut and Liver
  17. Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents
    Mami Takahashi, Michihiro Mutoh, Rikako Ishigamori, Gen Fujii, Toshio Imai · 2012 · Seminars in Immunopathology
  18. Parp‐1 genetic ablation in Ela–myc mice unveils novel roles for Parp‐1 in pancreatic cancer
    Neus Martínez‐Bosch, Mar Iglesias, Jessica Munné‐Collado, Carlos Manuel Martínez, Mireia Moreno, Carmen E. Guerra, José Yélamos, Pilar Navarro · 2014 · The Journal of Pathology
  19. Elevation in Multiple Serum Inflammatory Biomarkers Predicts Survival of Pancreatic Cancer Patients with Inoperable Disease
    Ahmed A. Alkhateeb, Lindsey Zubritsky, Brian J. Kinsman, Kim Leitzel, Cynthia Campbell‐Baird, Suhail M. Ali, James R. Connor, A. Lipton · 2014 · Journal of Gastrointestinal Cancer
  20. In vivo models of pancreatic ductal adenocarcinoma
    Vignesh Vudatha, Kelly M. Herremans, Devon C. Freudenberger, Christopher Liu, Jose Trevino · 2023 · Advances in cancer research
  21. Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
    Yu-Ching Fan, Yu-Cin Fong, Chun‐Tse Kuo, Chia-Wei Li, Wei‐Yu Chen, Jian-Da Lin, Florian Bürtin, Michael Linnebacher, Quoc Thang Bui, Kuan‐Der Lee et al. · 2023 · Cell & Bioscience
  22. Microbiomes in pancreatic cancer can be an accomplice or a weapon
    Xiaoyu Guo, Pan Wang, Yuan Li, Yawei Chang, X S Wang · 2024 · Critical Reviews in Oncology/Hematology
  23. The bifacial role of helminths in cancer: Involvement of immune and non-immune mechanisms
    Κατερίνα Οικονομοπούλου, Davor Brinc, Andreas Hadjisavvas, Georgios Christofi, Kyriacos C. Kyriacou, Eleftherios P. Diamandis · 2014 · Critical Reviews in Clinical Laboratory Sciences
  24. Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
    Yongde Luo, Xiaokun Li, Jianjia Ma, James L. Abbruzzese, Weiqin Lu · 2021 · Cancers
  25. Detection of Oncogene-Induced Senescence In Vivo
    Kwan‐Hyuck Baek, Sandra W. Ryeom · 2016 · Methods in molecular biology
  26. E47 Governs the MYC-CDKN1B/p27 KIP1 -RB Network to Growth Arrest PDA Cells Independent of CDKN2A/p16 INK4A and Wild-Type p53
    Kathleen M. Scully, Reyhaneh Lahmy, Lia Signaevskaia, Roman Šášik, Rachel Medal, Hee Jung Kim, Randall P. French, Brian P. James, Yifan Wu, Andrew M. Lowy et al. · 2018 · Cellular and Molecular Gastroenterology and Hepatology
  27. A novel pancreatic cancer model originated from transformation of acinar cells in adult tree shrew, a primate-like animal
    Qiu Tu, Dong Yang, Xianning Zhang, Xintong Jia, Sanqi An, Lanzhen Yan, Hongjuan Dai, Yuhua Ma, Chengwei Tang, Wei‐Min Tong et al. · 2019 · Disease Models & Mechanisms
  28. Cellular senescence occurred widespread to multiple selective sites in the fetal tissues and organs of mice
    Kexiong Zhang, Chengshu Chen, Yingying Liu, Hao Chen, Junping Liu · 2014 · Clinical and Experimental Pharmacology and Physiology
  29. FRA1 controls acinar cell plasticity during murine KrasG12D induced pancreatic acinar to ductal metaplasia
    Alina L. Li, Kensuke Sugiura, Noriyuki Nishiwaki, Kensuke Suzuki, Dorsay Sadeghian, Jun Zhao, A. Maitra, David Falvo, R. Chandwani, Jason R. Pitarresi et al. · 2024 · Developmental Cell
  30. Macroautophagy and the Oncogene-Induced Senescence
    Daniel Grasso, María I. Vaccaro · 2014 · Frontiers in Endocrinology
  31. Emerging frontiers in pancreatic cancer research
    Chandan Kumar‐Sinha, Iris H. Wei, Diane M. Simeone · 2012 · Current Opinion in Gastroenterology
  32. Physical and chemical insults induce inflammation and gastrointestinal cancers
    George S. Wilson, Jacob George · 2013 · Cancer Letters
  33. New concept: cellular senescence in pathophysiology of cholangiocarcinoma
    Motoko Sasaki, Yasuni Nakanuma · 2015 · Expert Review of Gastroenterology & Hepatology
  34. Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-β exposure
    Jesse Stone Handler, Jane E. Cullis, Antonina Avanzi, Emily Vucic, Dafna Bar‐Sagi · 2018 · Oncogene
  35. Unravelling the genetics and epigenetics of the ageing tumour microenvironment in cancer
    Hariharan Easwaran, Ashani T. Weeraratna · 2025 · Nature reviews. Cancer
  36. Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
    Junya Okabe, Takahiro Kodama, Yu Sato, Satoshi Shigeno, Takayuki Matsumae, Kazuma Daiku, Katsuhiko Sato, Teppei Yoshioka, Minoru Shigekawa, Masaya Higashiguchi et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  37. Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential
    Khem Raj Limbu, Rashmi Bhandari Chhetri, Su-Bin Kim, Jitendra Shrestha, Yoon Sin Oh, Dong Jae Baek, Eun‐Young Park · 2024 · Cancer Cell International
  38. Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancer
    Chiara Naro, Veronica Ruta, Claudio Sette · 2024 · Trends in Molecular Medicine
  39. Mutations in the p16 gene in DMBA-induced pancreatic intraepithelial neoplasia and pancreatic cancer in rats
    Zhu Zhu, Tao Liu, Fei Han, Sudong Zhan, Chunyou Wang · 2015 · Hepatobiliary & pancreatic diseases international
  40. GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma
    Juan Duan, Xiaoguang Li, Shan Hong Huang, Yanhua Zeng, Yan He, Hekun Liu, Dexin Lin, Dongdong Lu, Min Zheng · 2018 · Molecular Medicine Reports
  41. Pertussis: an update on primary prevention and outbreak control.
    P T Scott, J B Clark, William F. Miser · 1997 · PubMed
  42. CXCR2 Inhibition in Pancreatic Cancer: Opportunities for Immunotherapy?
    Jennifer P. Morton, Owen James Sansom · 2016 · Immunotherapy
  43. Extracellular matrix architecture promotes immunosuppressive microenvironments in pancreatic cancer
    Mackenzie K. Callaway, Brock J. Noonan, Kathryn L. Schwertfeger, Paolo P. Provenzano · 2025 · Matrix Biology
  44. A senescence restriction point acting on chromatin integrates oncogenic signals
    Stéphane Lopes‐Paciencia, Véronique Bourdeau, Marie‐Camille Rowell, Davoud Amirimehr, Jordan Guillon, Paloma Kalegari, Arnab Barua, Vincent Quoc‐Huy Trinh, Féryel Azzi, Simon Turcotte et al. · 2024 · Cell Reports
  45. The role of pancreatic and duodenal homeobox 1 as a therapeutic target in pancreatic cancer
    Volker Fendrich, Matthias Lauth · 2014 · Expert Opinion on Therapeutic Targets
  46. Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks
    Guillermo Urrutia, Thiago M. de Assuncao, Angela Mathison, Ann Salmonson, Romica Kerketta, Atefeh Zeighami, Timothy J. Stodola, Volkan N. Adsay, Burçin Pehlivanoğlu, Michael B. Dwinell et al. · 2021 · Frontiers in Cell and Developmental Biology
  47. A Carabrane-Type Sesquiterpenolide Carabrone from Carpesium cernuum Inhibits SW1990 Pancreatic Cancer Cells by Inducing Ferroptosis
    Yi-Dan Zheng, Ying Zhang, Junyi Ma, Chun‐Yan Sang, Jun‐Li Yang · 2022 · Molecules
  48. Inflammatory and alternatively activated macrophages independently induce metaplasia but cooperatively drive pancreatic precancerous lesion growth
    Geou‐Yarh Liou, Alicia K. Fleming Martinez, Heike R. Döppler, Ligia I. Bastea, Peter Störz · 2023 · iScience
  49. Inflammation-Related Pancreatic Carcinogenesis
    Juanjuan Dai, Mingjie Jiang, Xingpeng Wang, Ling Tian · 2017 · Pancreas
  50. Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer
    Ana S. Leal, Karen T. Liby · 2018 · Current Protocols in Pharmacology
  51. Expression of POU2F3 Transcription Factor Control Inflammation, Immunological Recruitment and Metastasis of Pancreatic Cancer in Mice
    Jennifer Bintz, Analía Meilerman Abuelafia, François Gerbe, Elodie Baudoin, Nathalie Auphan‐Anezin, Emmanuelle Sidot, Philippe Jay, Juan Iovanna · 2020 · Biology
  52. Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
    Liang Zhu, Jun‐Tao Ji, Jianjia Ma, Dan Wang, Muyun Liu, James Xianxing Du, Rong Chen, Wei Hou, James L. Abbruzzese, Craig D. Logsdon et al. · 2022 · Cancers
  53. Current methods in mouse models of pancreatic cancer.
    P. Mazur, A. Herner, Florian Neff, J. Siveke · 2015 · Methods in molecular biology
  54. NAD+ metabolism controls inflammation during senescence
    Timothy Nacarelli, Rugang Zhang · 2019 · Molecular & Cellular Oncology
  55. Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer
    Ligia I. Bastea, Xiang Liu, Alicia K. Fleming Martinez, Veethika Pandey, Heike R. Döppler, Brandy H. Edenfield, Murli Krishna, Lizhi Zhang, E. Aubrey Thompson, Paul M. Grandgenett et al. · 2024 · Nature Communications
  56. Macrophages in pancreatic cancer: Starting things off on the wrong track
    Xavier Deschênes‐Simard, Yusuke Mizukami, Nabeel M. Bardeesy · 2013 · The Journal of Cell Biology
  57. The Many Faces of Wnt and Pancreatic Ductal Adenocarcinoma Oncogenesis
    Colin D. Weekes, Robert A. Winn · 2011 · Cancers
  58. Pancreatic cancer: a mechanobiology approach
    Antonios Chronopoulos, Tyler Jacob Lieberthal, Armando E. del Río Hernández · 2017 · Convergent Science Physical Oncology
  59. Lipopolysaccharide (LPS) stimulation of Pancreatic Ductal Adenocarcinoma (PDAC) and macrophages activates the NLRP3 inflammasome that influences the levels of pro-inflammatory cytokines in a co-culture model
    Hariss G Paremes Sivam, Beek Yoke Chin, Sook Yee Gan, Jia Hao Ng, Agnes Gwenhure, Elaine Wan Ling Chan · 2023 · Cancer Biology & Therapy
  60. Deciphering cellular plasticity in pancreatic cancer for effective treatments
    Md. Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F. El‐Rayes, Herbert Chen, Philip A. Philip, Asfar Sohail Azmi · 2024 · Cancer and Metastasis Reviews
  61. Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile
    Baosheng Wang, Shaolong Sun, Zhen Liu · 2014 · Molecular Biology Reports
  62. Hereditary Pancreatitis Related to SPINK-1 Mutation. Is There an Increased Risk of Developing Pancreatic Cancer?
    Diego Tristán Enjuto Martínez, Norberto Herrera, Carmen Jiménez Ceinós, Antonio Ramos Bonilla, Rosa Llorente Lázaro, J Guerreiro, Pilar Castro-Carbajo · 2021 · Journal of Gastrointestinal Cancer
  63. Life's Essential 8, genetic susceptibility, and risk of incident pancreatic cancer: A prospective cohort study
    Zhuo Wu, Liangtang Zeng, Zhou Fang, Yuan Yuan, Yu Zhou, Rufu Chen · 2024 · International Journal of Cancer
  64. Clinical significance of pancreatic ductal metaplasia
    Tingting Jiang, Wei Fang, Keping Xie · 2022 · The Journal of Pathology
  65. Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor
    Lara Diego-González, Andrea Fernández‐Carrera, Ana Igea, Amparo Martínez-Pérez, Maria Elisabete C.D. Real Oliveira, Andreia Castro Gomes, Carmen E. Guerra, Mariano Barbacid, África González‐Fernández, Rosana Simón‐Vázquez · 2022 · Cancers
  66. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma
    Takashi Yamaguchi, Sanae Kabata Ikehara, Hayao Nakanishi, Yuzuru Ikehara · 2014 · The Journal of Pathology
  67. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma
    Zilong Zhang, Jin Shang, Zonglin Dai, Yutong Yao, Ying Kang Shi, Deyuan Zhong, Yuxin Liang, Chunyou Lai, Qinyan Yang, Tianhang Feng et al. · 2022 · Frontiers in Genetics
  68. Animal Models of Chronic Pancreatitis
    Anamika M. Reed · 2014
  69. Statistical experiment design for animal research
    Carlos Óscar S. Sorzano · 2023
  70. ER-phagy and proteostasis defects prime pancreatic epithelial state changes in KRAS-mediated oncogenesis
    Carla Salomo-Coll, Marisa Di Monaco, Jocelyn Holkham, Matthew Denman Smith, Morwenna Muir, Philippe Emmanuel Gautier, Hywel Dunn-Davies, Xiaozhong Zheng, Roopesh Krishnankutty, Alain J. Kemp et al. · 2025 · Developmental Cell
  71. An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer
    Sara Söderqvist, Annika Viljamaa, Natalie Geyer, Anna‐Lena Keller, Kseniya Ruksha, Carina Strell, Neda Hekmati, Alexandra Niculae, Jennie Engstrand, Ernesto Sparrelid et al. · 2025 · Nature Communications
  72. Stress granules are not present in Kras mutant cancers and do not control tumor growth
    Maxime Libert, Sophie Quiquempoix, Jean S. Fain, Sébastien Pyr dit Ruys, Malak Haidar, Margaux Wulleman, Gaëtan Herinckx, Didier Vertommen, Christelle Bouchart, Tatjana Arsenijevic et al. · 2024 · EMBO Reports
  73. Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA)
    Yalda Zolghadri, Shreoshi Pal Choudhuri, Ozhan Ocal, Somayeh Layeghi‐Ghalehsoukhteh, Feaven Berhe, Michael A. Hale, Thomas Martin Wilkie · 2017 · American Journal Of Pathology
  74. Senescence-Associated miRNAs and Their Role in Pancreatic Cancer
    Alexey Popov, Václav Mandys · 2022 · Pathology & Oncology Research
  75. Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation
    Jianjia Ma, Fanghua Gong, Eunice Kim, James Xianxing Du, Cindy Leung, Qingchun Song, Craig D. Logsdon, Yongde Luo, Xiaokun Li, Weiqin Lu · 2024 · Cancer Letters
  76. Protein kinase D enzymes: novel kinase targets in pancreatic cancer
    Geou‐Yarh Liou, Peter Störz · 2015 · Expert Review of Gastroenterology & Hepatology
  77. Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer
    Juliane Blümke, Moritz Schameitat, Atul Verma, Celina Limbecker, Elise Arlt, Sonja M. Kessler, Heike Kielstein, Sebastian Krug, Ivonne Bazwinsky‐Wutschke, Monika Hämmerle · 2025 · Cancers
  78. Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors
    Sara Barrambana, Elena Zamorano-Domínguez, Vasiliki Liaki, Carmen E. Guerra · 2025 · Advanced Drug Delivery Reviews
  79. Be like water, my cells: cell plasticity and the art of transformation
    Patrizia Cammareri, Kevin Myant · 2023 · Frontiers in Cell and Developmental Biology
  80. Oncogenic Signaling from the Plasma Membrane
    Eli Zamir, Nachiket Vartak, Philippe I. H. Bastiaens · 2013 · Springer eBooks
  81. Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer
    Xiaojia Li, Jie He, Keping Xie · 2022 · Cellular Oncology
  82. Nutritional imbalances linking cellular senescence and type 2 diabetes mellitus
    Roberto Testa, Stefano Genovese, Antonio Ceriello · 2014 · Current Opinion in Clinical Nutrition & Metabolic Care
  83. Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer
    Sang Hoon Lee, Seung Woo Park · 2015 · Korean Journal of Gastroenterology
  84. Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation
    A. Azevedo-Pouly, Michael A. Hale, Galvin H. Swift, C. Hoàng, Tye G. Deering, Jumin Xue, Thomas M. Wilkie, L. Murtaugh, Raymond J. MacDonald · 2023 · PLoS ONE
  85. A mathematical model for pancreatic cancer during intraepithelial neoplasia
    Joshua Briones-Andrade, Guillermo Ramı́rez-Santiago, J. Roberto Romero-Arias · 2024 · Royal Society Open Science
  86. 2. Pathogenesis and Pathobiology in Pancreatic Cancer. -The Molecular Mechanisms of Carcinogenesis, and Invasion and Metastasis in Pancreatic Cancer-.
    Kennichi Satoh, Tooru Shimosegawa · 2012 · Nihon Naika Gakkai Zasshi
  87. Telomere in Aging and Age-Related Diseases
    Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya · 2017 · The Indonesian Biomedical Journal
  88. Inflammation and de-differentiation in pancreatic carcinogenesis
    Takahiro Seimiya, Motoyuki Otsuka, Takuma Iwata, Eri Tanaka, Tatsunori Suzuki, Kazuma Sekiba, Mari Yamagami, Rei Ishibashi, Kazuhiko Koike · 2018 · World Journal of Clinical Cases
  89. Organoids
    Bernat Navarro-Serer, Laura DeLong Wood · 2022 · Pancreas
  90. The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of Mice
    Ana S. Leal, Karen T. Liby · 2024 · International Journal of Molecular Sciences
  91. Neutrophil count kinetics during the first cycle of chemotherapy predicts the outcome of patients with locally advanced or metastatic pancreatic cancer
    Giuseppe A. Colloca, Antonella Venturino, Domenico Guarneri · 2020 · Asia-Pacific Journal of Clinical Oncology
  92. Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
    Sam Garnett, Angeline de Bruyns, Veronique Provencher-Tom, Kendall Dutchak, Ran Shu, David L. Dankort · 2021 · Molecular Cancer Research
  93. Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice
    Amparo Martínez-Pérez, Lara Diego-González, Manuel Vilanova, Alexandra Correia, Rosana Simón‐Vázquez, África González‐Fernández · 2023 · Frontiers in Immunology
  94. Measurement of Reactive Oxygen Species by Fluorescent Probes in Pancreatic Cancer Cells
    Yongde Luo, Dan Wang, James L. Abbruzzese, Weiqin Lu · 2018 · Methods in molecular biology
  95. In vivo Mouse Models of Pancreatic Ductal Adenocarcinoma
    Carmen Mota · 2021
  96. A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia
    Emanuele Middonti, Elena Astanina, Edoardo Vallariello, Roxana Maria Hoza, Jasna Metović, Rosella Spadi, Carmen Cristiano, Mauro Giulio Papotti, Paola Allavena, Francesco Novelli et al. · 2024 · EMBO Reports
  97. Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene
    Chen Liang, Zhen Wang, Li Wu, Chen Wang, Baohua Yu, Xiuzhong Yao, Xiao-Lin Wang, Yingyi Li · 2015 · Tumor Biology
  98. Macrophage-induced reactive oxygen species in the initiation of pancreatic cancer: a mini-review
    Heike R. Döppler, Peter Störz · 2024 · Frontiers in Immunology
  99. The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis
    Manon Brunet, Claire Vargas, Marjorie Fanjul, Damien Varry, Naïma Hanoun, Dorian Larrieu, Laetitia Pieruccioni, Guillaume Labrousse, Hubert Lulka, Florence Capilla et al. · 2024 · The Journal of Pathology
  100. NFAT in Pancreatic Carcinogenesis
    Elisabeth Heßmann · 2014 · Journal of Carcinogenesis & Mutagenesis